Back
Intellia Therapeutics Stock Predictions
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
36
NTLA
Intellia Therapeutics
Last Price:
$8.52
Seasonality Move:
27.3%
7 Day Trial
ALL ACCESS PASS
$
7
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.Intellia Therapeutics Stock Forecast
-
Over the next 52 weeks, Intellia Therapeutics has on average historically risen by 26.1% based on the past 8 years of stock performance.
-
Intellia Therapeutics has risen higher in 3 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%
-
Is Intellia Therapeutics Stock Undervalued?The current Intellia Therapeutics [NTLA] share price is $8.50. The Score for NTLA is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
NTLA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Intellia Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Intellia Therapeutics has on average historically risen by 26.1% based on the past 8 years of stock performance.
Intellia Therapeutics Stock Rating
Sell
36
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics overpriced?
-
Intellia Therapeutics has risen higher in 3 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%
Intellia Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
intelliatx.com
52-Week Data
52-Week High:
28.18
52-Week Low:
5.90
Prediction Charts
Market Cap:
880.5M
Price in USD:
8.50
Volume:
2.5M
Beta:
2.07
Technical Analysis
SMA50:
8.17
SMA100:
9.48
SMA200:
14.24
52-Wk Change:
-67.52%
Stock Predictions
-
Is Intellia Therapeutics stock public?Yes, Intellia Therapeutics is a publicly traded company.
-
What is the Intellia Therapeutics stock quote today?The Intellia Therapeutics stock price is 8.50 USD today.
-
How to buy Intellia Therapeutics stock online?You can buy Intellia Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-29 | 8.57 | 8.20 | 8.64 | 8.16 |
| Apr-30 | 8.04 | 8.87 | 8.94 | 7.90 |
| May-1 | 8.90 | 8.64 | 8.90 | 8.49 |
| May-2 | 8.74 | 8.84 | 9.27 | 8.67 |
| May-5 | 8.70 | 8.44 | 8.81 | 8.43 |
| May-6 | 8.23 | 7.25 | 8.24 | 7.24 |
| May-7 | 7.39 | 7.29 | 7.50 | 7.21 |
| May-8 | 7.88 | 8.28 | 8.54 | 7.24 |
| May-9 | 8.42 | 8.12 | 8.71 | 8.05 |
| May-12 | 8.45 | 8.55 | 8.89 | 8.43 |
| May-13 | 8.56 | 8.32 | 8.75 | 8.00 |
| May-14 | 8.34 | 7.88 | 8.54 | 7.65 |
| May-15 | 7.85 | 8.08 | 8.09 | 7.62 |
| May-16 | 8.14 | 8.50 | 8.52 | 8.03 |
Intellia Therapeutics Earnings
Intellia Therapeutics Earnings Report: Per Share Intellia Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Intellia Therapeutics Forecast Revenue Growth
Intellia Therapeutics Stock Analysis: Historical quarterly revenues per share for Intellia Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.08 per share, an increase this year of $1.08 per share, and an increase next year of $0.23 per share.
* Intellia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.